Accellta Ltd

Accellta: Adding a New Dimension to Stem Cells, One Breakthrough at a Time. Imagine a world where stem cell therapies are no longer a distant dream, but an accessible reality. Accellta isnt just developing cutting-edge stem cell manufacturing solutions; were propelling the entire regenerative medicine industry forward, one collaborative partnership at a time. Unlike traditional methods riddled with high costs and slow production, Accelltas revolutionary 3D suspension technology unlocks the true potential of stem cells. Our proprietary platform slashes manufacturing costs by over 90% and speeds up production by 65%. Think about it: No more feeder cells, no more microcarriers,...

Expansion & differentiation of hscs in non-adherent 3d suspension culture systems,differentiation of hpscs into germ-layer,progenitor & fully differentiated cells,and custom-made solutions for cost-effective mass-production of high-quality clinical grade scs

Accellta ltd operates in the Biotechnology research industry.

Accellta ltd's revenue is 11m - 100m

Accellta ltd has 11 - 50 employees.